Rothbart

18 results.

October 20, 2021 American Cancer Society grant to support Van Andel Institute research into anti-cancer medications

GRAND RAPIDS, Mich. (Oct. 20, 2021) — Van Andel Institute’s Scott Rothbart, Ph.D., has earned a four-year, $792,000 Research…

October 20, 2021 Meet the scientist behind the science: Dr. Scott Rothbart

Earlier today, we announced that Van Andel Institute Associate Professor Dr. Scott Rothbart has been awarded a Research Scholar Grant from…

September 22, 2021 Coriell Institute for Medical Research, Van Andel Institute awarded estimated $12.4 million SPORE grant from National Cancer Institute

Estimated at $12.4 million, this five-year grant supports a nationwide team of researchers investigating epigenetic therapies for cancer The Coriell Institute for Medical Research and…

May 17, 2021 Graduate student spotlight: Creating tools to understand the body’s molecular workforce

Throughout the year, we highlight Van Andel Institute Graduate School’s doctoral students. This month, we’re featuring Ariana Kupai, a Ph.D. candidate in the lab of Dr.…

November 20, 2020 After more than a decade, ChIP-seq may be quantitative after all

GRAND RAPIDS, Mich. (Nov. 20, 2020) — For more than a decade, scientists studying epigenetics have used a powerful method called ChIP-seq to map changes…

April 4, 2019 Blocking epigenetic “Swiss army knife” may be a new strategy for treating colorectal cancer

GRAND RAPIDS, Mich. (April 4, 2019) — A new study out today in Cancer Cell shows that blocking specific regions of a protein called…

December 5, 2018 Teaming up to accelerate scientific discovery

How close collaboration between academic labs, the biotech sector and a highly competitive federal grant program bolsters biomedical research innovation and cutting-edge technology development In…

November 28, 2018 High-throughput platform enables scientists to map activity of an emerging class of cancer drug targets

GRAND RAPIDS, Mich. (Nov. 28, 2018) — A powerful new biochemical platform is fueling the study of a family of enzymes that are promising targets for…